Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sengottayan VK et al. - The authors have assessed the usefulness of celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in the management of refractory nocturia in patients with benign prostatic hyperplasia (BPH). Celecoxib was an effective treatment option for patients with BPH with nocturia.



Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address